BG
SGYP

BlackRock Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$539K Buy
88,424
+21,502
+32% +$112K ﹤0.01% 2329
2016
Q3 		$368K Buy
66,922
+32,513
+94% +$152K ﹤0.01% 2415
2016
Q2 		$130K Sell
34,409
-532
-2% -$1.8K ﹤0.01% 2708
2016
Q1 		$96K Buy
34,941
+14,201
+68% +$51.4K ﹤0.01% 2778
2015
Q4 		$118K Sell
20,740
-709
-3% -$4.32K ﹤0.01% 2645
2015
Q3 		$114K Buy
21,449
+5,012
+30% +$38.8K ﹤0.01% 2679
2015
Q2 		$136K Buy
+16,437
New +$79.7K ﹤0.01% 2677

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return